NUVERRA ENVIR SOL
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, and Vietnam. The company owns and operates the Thomson Medical Centre, as well as a network of medical clinics and facilities. It also offers urgent care services, such as basic resuscitation, ECG, vaccinations, IM/IV fluid and IV antibiotic administration, sur… Read more
NUVERRA ENVIR SOL (3H5) - Net Assets
Latest net assets as of December 2025: €565.48 Million EUR
Based on the latest financial reports, NUVERRA ENVIR SOL (3H5) has net assets worth €565.48 Million EUR as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.78 Billion) and total liabilities (€1.22 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €565.48 Million |
| % of Total Assets | 31.71% |
| Annual Growth Rate | -0.79% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 5.2 |
NUVERRA ENVIR SOL - Net Assets Trend (2020–2024)
This chart illustrates how NUVERRA ENVIR SOL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NUVERRA ENVIR SOL (2020–2024)
The table below shows the annual net assets of NUVERRA ENVIR SOL from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €548.43 Million | -4.95% |
| 2023-12-31 | €577.00 Million | +0.27% |
| 2022-12-31 | €575.44 Million | -5.41% |
| 2021-12-31 | €608.34 Million | +7.47% |
| 2020-12-31 | €566.03 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to NUVERRA ENVIR SOL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 13.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €111.34 Million | 23.64% |
| Other Components | €359.56 Million | 76.36% |
| Total Equity | €470.89 Million | 100.00% |
NUVERRA ENVIR SOL Competitors by Market Cap
The table below lists competitors of NUVERRA ENVIR SOL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Asia Tech Image
TWO:4974
|
$95.86 Million |
|
Afyon Cimento Sanayi TAS
IS:AFYON
|
$95.95 Million |
|
Rafael Microelectronics
TWO:6568
|
$95.97 Million |
|
Hi-Tech Pipes Limited
NSE:HITECH
|
$95.99 Million |
|
Sunfun Info Co. Ltd.
TWO:5278
|
$95.76 Million |
|
Gaming Realms plc
OTCQX:PSDMF
|
$95.74 Million |
|
Taylor Calvin B Bksh
OTCQX:TYCB
|
$95.73 Million |
|
Xplora Technologies As
OL:XPLRA
|
$95.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NUVERRA ENVIR SOL's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 499,722,000 to 470,895,000, a change of -28,827,000 (-5.8%).
- Net loss of 47,576,000 reduced equity.
- Other factors increased equity by 18,749,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-47.58 Million | -10.1% |
| Other Changes | €18.75 Million | +3.98% |
| Total Change | €- | -5.77% |
Book Value vs Market Value Analysis
This analysis compares NUVERRA ENVIR SOL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.08x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | €0.02 | €0.04 | x |
| 2021-12-31 | €0.02 | €0.04 | x |
| 2022-12-31 | €0.02 | €0.04 | x |
| 2023-12-31 | €0.02 | €0.04 | x |
| 2024-12-31 | €0.02 | €0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NUVERRA ENVIR SOL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -10.10%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -12.05%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 3.79x
- Recent ROE (-10.10%) is below the historical average (2.61%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 2.91% | 5.92% | 0.19x | 2.62x | €-34.75 Million |
| 2021 | 10.11% | 16.11% | 0.24x | 2.57x | €593.90K |
| 2022 | 7.32% | 10.27% | 0.25x | 2.90x | €-13.39 Million |
| 2023 | 2.83% | 4.03% | 0.19x | 3.62x | €-35.82 Million |
| 2024 | -10.10% | -12.05% | 0.22x | 3.79x | €-94.67 Million |
Industry Comparison
This section compares NUVERRA ENVIR SOL's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,652,983,276
- Average return on equity (ROE) among peers: 9.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NUVERRA ENVIR SOL (3H5) | €565.48 Million | 2.91% | 2.15x | $95.85 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| Apollo Medical Holdings Inc (3AM) | $510.64 Million | 13.50% | 0.70x | $820.67 Million |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.04 Billion | 6.61% | 0.54x | $9.60 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Eifelhöhen-Klinik AG (EIF) | $18.66 Million | 24.17% | 2.10x | $4.38 Million |
| Garofalo Health Care S.p.A (GHC) | $333.14 Million | 6.51% | 1.55x | $126.70 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |